date
variou
strategi
includ
viral
nonvir
vector
develop
gene
transfer
among
viral
vector
adenoviru
ad
vector
deliv
gene
wide
varieti
cell
type
tissu
independ
prolif
state
review
ref
vector
modifi
introduc
delet
earli
gene
increas
clone
capac
reduc
cellular
howev
modif
lead
prolong
transgen
express
rodent
nonhuman
primat
indic
residu
low
level
express
ad
gene
respons
least
part
shortterm
persist
gutless
helperdepend
adenoviru
vector
hd
allow
transgen
express
persist
almost
entir
lifetim
mous
shown
liver
brain
vector
lack
viral
code
sequenc
produc
coinfect
suitabl
cell
line
ad
helper
viru
provid
tran
protein
requir
replic
light
extens
clone
capac
kb
persist
express
mani
cell
type
hd
vector
ideal
vector
studi
gene
function
absenc
interf
viral
promot
undesir
express
potenti
toxic
ad
gene
reduc
immun
respons
ad
protein
achiev
safe
effect
protein
express
pharmacolog
control
level
gene
transcript
requir
place
gene
activ
control
outsid
via
effector
molecul
allow
activ
limit
within
desir
window
thu
express
adjust
accord
evolut
induc
biolog
effect
treatment
termin
drug
withdraw
differ
system
base
smallmolecul
control
transcript
develop
proven
effect
mice
rapamycinregul
system
rr
use
dimer
drug
bring
togeth
function
unit
bipartit
transcript
differ
chimer
system
base
progesteron
antagonist
hd
vector
express
human
growth
hormon
hgh
control
system
effect
control
hgh
express
induc
biolog
respons
limit
period
tet
system
wide
appli
vitro
vivo
deriv
element
tetracyclin
tc
resist
operon
escherichia
coli
convert
eukaryot
transcript
activ
one
version
tetcontrol
transactiv
tta
fusion
tet
repressor
protein
tetr
eukaryot
transcript
activ
domain
bind
tet
oper
sequenc
fuse
minim
promot
activ
transcript
absenc
addit
tc
one
deriv
doxycyclin
dox
abolish
transcript
second
version
mutat
form
tta
rtta
bind
activ
transcript
presenc
tet
system
use
gene
therapi
model
wherebi
varieti
vector
appli
retrovirus
adenoassoci
viru
aav
binari
system
first
gener
adenovirus
electropor
despit
numer
success
applic
tet
regulatori
system
origin
describ
show
limit
rtta
exhibit
residu
affin
teto
absenc
dox
requir
rel
high
level
dox
achiev
full
activ
addit
rtta
possibl
mrna
rather
suscept
degrad
least
certain
cell
type
limit
overcom
novel
rtta
version
identifi
via
mutagenesi
genet
select
yeast
new
transactiv
speci
subsequ
embed
synthet
sequenc
design
optim
express
mammal
show
drastic
improv
paramet
mention
pharmacolog
control
gene
express
may
critic
applic
util
pleiotrop
cytokin
current
use
treatment
viral
hepat
effect
antivir
treatment
hbv
infect
obtain
introduc
asialoglycoprotein
bind
site
recombin
turn
led
higher
intrahepat
gene
transfer
may
offer
possibl
limit
express
potenti
reduct
sideeffect
tissu
central
nervou
system
provid
transgen
express
kept
within
safe
therapeut
level
antivir
action
thought
mediat
transcript
activ
mani
gene
includ
oligoadenyl
synthetas
oa
gtpase
report
featur
regul
express
explor
util
novel
transactiv
carri
singl
hd
vector
hdtetifn
efficaci
doxregul
express
verifi
murin
model
acut
hepat
liver
protect
depend
activ
express
induc
dox
treatment
secret
cytokin
repeatedli
reinduc
high
level
period
month
control
amount
dox
deliv
addit
mice
inject
low
hdtetifn
dose
result
doxmedi
regul
liver
restrict
express
associ
induct
antivir
gene
result
indic
desir
level
express
achiev
maintain
control
vector
dosag
transcript
activ
control
express
induc
cassett
base
tet
system
construct
figur
tetracyclinesensit
transactiv
clone
liverspecif
ttr
promot
enhanc
follow
polyadenyl
signal
gene
insert
opposit
orient
control
follow
bgh
polyadenyl
signal
increas
mrna
stabil
two
intron
insert
upstream
transactiv
gene
respect
express
cassett
insert
helperdepend
backbon
vector
gener
phdtetifn
plasmid
hdtetifn
vector
rescu
amplifi
cell
use
helper
compar
vitro
potenc
express
mediat
hdtetifn
hdifn
express
directli
ttr
promot
cell
treat
ppcell
releas
medium
measur
day
pi
figur
hdtetifntr
cell
doxdepend
induct
product
observ
lower
valu
observ
hdifntreat
cell
visual
cell
express
function
vector
dose
treat
increas
amount
hdtetifn
express
reveal
immunohistochemistri
assay
correl
observ
vector
dose
cell
stain
antibodi
doxtreat
cell
wherea
posit
stain
observ
absenc
dox
even
cell
treat
hdtetifn
highest
dose
ppcell
figur
result
indic
hdtetifn
allow
signific
express
control
vitro
dox
verifi
effici
persist
secret
mice
inject
iv
pp
hdifn
hdtetifn
releas
serum
measur
time
previous
report
circul
detect
dosag
hdifntreat
mice
differ
hdtetifninject
mice
serum
observ
dosag
start
day
pi
day
dox
treatment
figur
averag
uml
detect
treat
mice
n
remov
dox
result
rapid
decreas
serum
undetect
level
day
uml
therefor
express
increas
least
express
kinet
function
dox
treatment
observ
throughout
month
analyz
hdtetifn
inject
muscl
lead
detect
serum
present
serum
indic
liver
specif
maintain
express
vector
data
shown
verifi
level
releas
blood
stream
function
dox
ad
drink
water
mice
treat
day
differ
dox
concentr
shown
figur
clear
correl
observ
concentr
dox
drink
water
serum
measur
vsv
elisa
assay
concentr
serum
rang
uml
wherea
uml
lowest
dox
concentr
serum
detect
sensit
albeit
quantit
elisa
assay
result
line
observ
transgen
mice
reduct
amount
dox
ad
drink
water
result
lower
amount
luciferas
detect
character
kinet
express
induc
singl
oral
dose
dox
mice
inject
pp
serum
measur
time
figur
dose
mgkg
dox
rapid
induct
express
observ
earli
h
induct
maxim
express
observ
h
valu
rang
uml
serum
level
return
background
within
h
rapid
kinet
express
allow
precis
measur
peak
valu
mous
may
explain
least
part
fivefold
variat
maxim
express
mgkg
dox
higher
level
observ
indic
maxim
induct
may
achiev
singl
dose
mgkg
dox
data
shown
overal
result
show
context
hdad
vector
allow
longterm
dosedepend
dox
regul
gene
express
liver
investig
therapeut
potenc
regul
express
gene
assess
antivir
strength
hdtetifn
acut
hepat
model
purpos
examin
effect
hdtetifn
infect
suscept
mous
strain
mous
coronaviru
treatment
recombin
type
shown
prolong
surviv
follow
exposur
particularli
treatment
initi
viral
mice
inject
iv
pp
hdtetifn
induct
measur
day
pi
expect
inject
mice
treat
dox
drink
water
concentr
day
circul
observ
rang
uml
return
basal
level
day
dox
withdrawl
day
pi
subgroup
mice
reinduc
dox
condit
describ
mice
infect
day
ip
inject
pfu
verifi
impact
induct
liver
damag
transaminas
alt
present
serum
measur
day
infect
figur
hepat
protect
observ
mice
preinduc
dox
serum
transaminas
level
remain
basal
level
howev
sharp
rise
serum
alt
level
observ
mice
inject
hdtetifn
treat
dox
control
mice
mock
addit
effect
observ
doxtreat
mice
slight
signific
prolong
mean
surviv
time
p
shown
figur
control
mice
treat
dox
die
day
infect
wherea
doxtreat
group
one
six
surviv
till
day
experi
termin
mean
surviv
time
standard
deviat
mock
day
dox
dox
therefor
experi
demonstr
doxdepend
express
result
liver
protect
prolong
surviv
infect
mice
previous
shown
inject
low
dose
hdifn
vector
give
rise
intrahepat
product
cytokin
without
detect
therefor
examin
whether
result
could
also
obtain
tetregul
vector
balbc
mice
iv
inject
differ
dose
hdtetifn
measur
day
pi
treatment
day
dox
present
drink
water
figur
mice
inject
low
vector
dose
pp
pp
treat
dox
detect
neither
liver
serum
howev
liverrestrict
rang
ug
observ
upon
induct
depend
vector
dose
higher
hdtetifn
dose
pp
absenc
dox
treatment
result
ug
present
liver
serum
dox
treatment
level
increas
liver
serum
level
return
background
upon
dox
withdraw
day
later
data
shown
balbc
mice
ad
less
liverrestrict
induc
viru
dose
pp
wherea
lower
vector
dose
cytokin
undetect
hdtetifn
dose
result
liverrestrict
express
analyz
induct
respons
gene
figur
agreement
presenc
protein
northern
blot
analysi
show
clear
signal
mrna
balbc
doxtreat
mice
lane
consequ
express
oa
tgtp
transcript
elev
indic
rnase
protect
assay
lane
c
threefold
induct
oa
signal
observ
highest
hdtetifn
dose
indic
balbc
respect
compar
oa
induct
tgtp
background
less
pronounc
examin
revers
induct
antivir
gene
activ
oa
tgtp
transcript
examin
day
dox
withdraw
time
point
mice
inject
pp
previous
induc
dox
mrna
synthesi
antivir
gene
return
basal
level
evalu
cell
type
express
upon
dox
treatment
immunohistochemistri
antibodi
perform
liver
figur
posit
hepatocyt
observ
proxim
vessel
upon
dox
induct
lastli
inflamm
evalu
rnase
protect
assay
mrna
infiltr
lymphocyt
eg
macrophag
marker
elev
hdtetifninject
mice
independ
dox
treatment
data
shown
experi
indic
liverrestrict
express
induc
mous
strain
without
appar
liver
damag
control
dose
vector
regul
via
dox
express
gene
studi
show
featur
doxdepend
express
deliv
hd
vector
among
differ
vector
use
gene
transfer
adenoviru
vector
emerg
one
effici
transduc
liver
limit
transgen
express
liver
transactiv
clone
downstream
liverspecif
promoterenhanc
ttr
gene
insert
tet
respons
promot
headtohead
configur
vector
hdtetifn
figur
tight
control
express
observ
cell
use
differ
amount
vector
figur
abil
control
express
therapeut
gene
within
relev
safe
window
major
prerequisit
varieti
regimen
envis
gene
therapi
rapid
adjust
activ
therapeut
gene
progress
diseas
particular
import
hdtetifn
vector
meet
sever
requir
inject
larg
dose
pp
mice
result
undetect
serum
level
absenc
dox
figur
upon
induct
dox
detect
serum
express
correl
amount
dox
deliv
anim
figur
high
level
secret
observ
largest
dose
dox
slight
variat
period
month
although
rapid
induct
secret
cytokin
alreadi
wide
report
rapid
revers
induct
repres
major
improv
previous
describ
system
rapamycin
system
explor
context
ad
aav
vector
demonstr
rapid
induct
hgh
control
express
wide
rang
howev
hgh
remain
basal
level
day
singl
inject
induc
similar
slow
deinduct
kinet
observ
brain
rat
use
tetoff
system
deliv
first
gener
ad
improv
revers
induct
regul
system
carri
hd
vector
driven
ttr
promot
use
studi
interestingli
burcin
et
observ
similarli
ineffici
induct
report
gene
earli
stage
hd
inject
system
experi
requir
understand
week
appear
requir
reach
steadi
state
express
sinc
full
induct
tetcontrol
gene
achiev
within
less
h
liver
transgen
factor
immunorespons
ad
particl
may
detriment
effect
transcript
earli
stage
one
limit
actual
base
system
poor
sensit
dox
experiment
condit
satur
use
mgkg
figur
howev
parallel
transactiv
develop
show
higher
sensit
dox
hela
cell
interest
explor
addit
transactiv
context
hd
vector
may
bring
dox
requir
within
dose
rang
human
antibiot
therapi
appar
long
persist
sustain
reinduc
express
figur
immunocompet
mice
indic
transactiv
immunogen
although
presum
use
liverspecif
promot
ttr
express
transactiv
hepat
cell
profession
antigen
present
cell
may
contribut
persist
hypothesi
agreement
previou
report
show
longterm
transgen
express
context
first
gener
ad
vector
presenc
liverspecif
studi
liver
protect
challeng
observ
upon
doxmedi
induct
express
figur
strike
differ
observ
associ
dox
treatment
signific
view
fact
viral
prepar
inject
group
elimin
experiment
bia
differ
transduc
particl
per
unit
volum
puriti
vector
prepar
dilut
volum
addit
liver
protect
achiev
week
hdtetifn
inject
line
notion
therapeut
effect
mediat
helperdepend
vector
persist
long
period
time
previous
show
lower
level
serum
associ
partial
hepat
protect
effect
surviv
studi
mice
treat
dox
show
liver
protect
one
six
surviv
infect
figur
higher
level
circul
may
elicit
stronger
local
peripher
effect
induct
antivir
gene
periton
macrophag
activ
may
limit
replic
effici
manner
although
show
inject
hdtetifn
result
doxdepend
hepat
protect
impact
gene
therapi
approach
chronic
hepat
remain
establish
mous
model
diseas
exist
unlik
hbv
woodchuck
model
hcv
infect
nonhuman
primat
chimpanze
howev
pharmacolog
control
express
also
requir
context
anim
model
light
safeti
concern
toxic
sideeffect
adjust
level
function
diseas
progress
recombin
wide
use
treatment
human
hepat
b
c
howev
system
inject
associ
sideeffect
particularli
neuron
system
caus
withdraw
signific
number
patient
therapi
therefor
interest
evalu
possibl
limit
biolog
respons
induc
express
liver
function
dox
treatment
vector
dosag
previou
studi
observ
mice
inject
hdifn
express
directli
constitut
ttr
promot
liverrestrict
express
well
induct
antivir
gene
last
month
data
shown
observ
agreement
recent
report
gene
transfer
mediat
hd
vector
result
long
persist
transgen
long
period
express
could
nonetheless
consid
overtherapeut
light
current
treatment
hcv
last
month
use
hdtetifn
vector
howev
allow
control
time
potenc
express
basi
dox
treatment
even
low
vector
dose
inde
low
dose
hdtetifn
result
detect
liver
bloodstream
upon
dox
induct
figur
consequ
liverrestrict
express
antivir
gene
induc
figur
absenc
liver
damag
inflamm
respons
also
liver
revers
induct
fairli
rapid
indic
reduct
antivir
gene
mrna
day
dox
withdraw
lastli
express
highlight
hepatocyt
cell
upon
dox
treatment
figur
expect
basi
previou
experi
marker
gene
doxdepend
express
distribut
hepatocyt
proxim
vessel
use
hd
vector
transactiv
allow
express
transgen
regul
long
period
time
within
express
window
either
restrict
liver
circul
protein
lack
detect
immunorespons
hdtetifn
associ
prolong
reinduc
candid
vector
regul
system
gene
therapi
purpos
least
applic
altern
option
use
transgen
anim
tissuespecif
express
germlin
transgenesi
gener
use
anim
model
genet
studi
costli
timeconsum
addit
requir
use
larg
number
anim
limit
toxic
embryogenesi
featur
system
describ
paper
allow
studi
gene
function
within
specif
cell
varieti
anim
model
includ
nonhuman
primat
hd
vectormedi
gene
transfer
cell
grown
mem
supplement
heatinactiv
fc
mous
fibroblast
human
hepatoma
cell
grown
dmem
supplement
fc
mice
use
studi
immunocompet
week
old
time
inject
balbc
femal
purchas
charl
river
lecco
itali
group
four
five
mice
receiv
inject
tail
vein
adenoviru
vector
dilut
physiolog
solut
volum
dox
sucros
ph
ad
drink
water
indic
timepoint
blood
obtain
retroorbit
bleed
serum
store
indic
time
mice
kill
organ
rapidli
frozen
liquid
nitrogen
store
transactiv
gene
recov
plasmid
ecoribamhi
fragment
subclon
vector
pttrbgh
contain
liverspecif
transthyretin
gene
minim
enhanc
promot
bovin
growth
hormon
polya
site
bgh
improv
level
express
artifici
intron
amplifi
pcr
invitrogen
carlsbad
ca
usa
subclon
hindiiiecori
ttr
promoterenhanc
mifn
cdna
gener
intron
vector
pvijnsa
saciiecori
fragment
subclon
vector
tre
tet
respons
element
polyadenyl
site
paci
site
noti
site
insert
respect
upstream
downstream
polya
pcr
point
treintron
fragment
excis
xhoikpni
fragment
insert
thu
gener
gene
amplifi
pcr
ad
bamhi
site
paci
site
subclon
gener
construct
express
cassett
excis
noti
subclon
noti
site
rescu
hdtetifn
vector
plasmid
cleav
pmei
transfect
subsequ
cell
infect
helper
adenoviru
titer
hd
vector
amplif
passag
cell
follow
infect
cell
lysat
passag
determin
amount
cell
supernat
without
dox
h
infect
vsv
inhibit
assay
multipl
viral
passag
perform
reach
high
titer
vector
purifi
doubl
cscl
gradient
physic
particl
measur
optic
densiti
dna
viral
cytopath
inhibit
assay
use
vescicular
stomat
viru
vsv
describ
elsewher
activ
express
unitsml
activ
calibr
standard
recombin
calbiochem
san
diego
ca
usa
ninetysixwel
plate
coat
overnight
rat
ascit
monoclon
ab
clone
yamasa
corpor
japan
carbon
buffer
mm
ph
block
bsa
pb
tween
h
sampl
ad
incub
h
rt
bsa
pb
tween
subsequ
plate
wash
three
time
pb
tween
incub
h
rt
polyclon
ab
rdi
dilut
bsa
pb
tween
well
wash
incub
antisheep
igg
ap
conjug
sigma
st
loui
mo
usa
dilut
bsa
pb
tween
h
rt
final
detect
done
ad
pnitrophenyl
phosphat
disodium
mgml
diethanolammin
buffer
ph
contain
mm
read
od
standard
use
refer
experi
liver
weigh
homogen
pb
use
polytron
homogen
lysat
centrifug
min
rpm
elimin
cell
debri
sinc
acid
stabl
hcl
n
ad
reach
ph
extract
incub
overnight
neutral
ph
reach
ad
naoh
centrifug
min
rpm
clarifi
extract
analyz
vsv
inhibit
assay
frozen
tissu
mechan
pulver
rna
isol
tissu
use
ultraspec
rna
reagent
biotecx
laboratori
accord
manufactur
instruct
total
rna
use
northern
blot
analysi
intens
band
quantifi
phosphorimag
analysi
rnase
protect
assay
quantif
mrna
perform
use
riboqu
multiprob
rpa
assay
system
pharmingen
san
diego
ca
usa
accord
manufactur
instruct
probe
set
pathway
activ
kindli
provid
iain
campbel
scripp
san
diego
ca
usa
extent
hepatocellular
injuri
induc
adenoviru
inject
monitor
measur
serum
alanin
aminotransferas
alt
activ
indic
timepoint
alt
activ
measur
spotchem
model
accord
manufactur
instruct
cell
stain
h
infect
cell
wash
pb
fix
pb
formaldehyd
min
rt
tissu
stain
indic
timepoint
liver
harvest
hdtetifninject
mice
fix
pb
paraformaldehyd
h
incub
overnight
pb
sucros
liver
includ
oct
store
cell
liver
section
wash
twice
pb
incub
glycin
min
rt
wash
pb
sampl
permeabil
min
treat
pb
goat
serum
min
rt
sampl
incub
h
rt
rat
ascit
monoclon
ab
antimifn
clone
yamasa
corpor
dilut
pb
goat
serum
wash
five
time
pb
second
incub
antirat
igg
ap
conjug
sigma
st
loui
mo
usa
antibodi
dilut
goat
serum
perform
h
subsequ
wash
sampl
incub
ap
substrat
mm
nacl
mm
mm
triscl
ph
nbt
bcip
suffici
stain
reach
wash
pb
mount
aquatex
describ
mous
hepat
viru
type
amplifi
mous
fibroblast
dbt
cell
titer
measur
standard
plaqu
assay
total
pfu
inject
intraperiton
ip
physiolog
solut
